Olá você está no Território Parkinson
Aqui o que importa não é a velocidade de sua jornada mas sim a sua persistência continuar seguindo em frente.
Lembre-se que você não está sozinho nesta jornada
🛠️ O Território Parkinson está em construção, e você faz parte disso!Estamos começando esse espaço com muito cuidado e propósito. Cada conteúdo é feito pensando em quem convive com o Parkinson — direta ou indiretamente.Por isso, seu retorno, opinião e sugestões são muito importantes! Eles nos ajudam a melhorar e construir um site cada vez mais útil e verdadeiro.🗓️ Toda semana teremos um novo post. Queremos caminhar ao seu lado, com informação de qualidade e abertura ao diálogo.Você já faz parte do Território Parkinson. Vamos juntos nessa jornada!
Quando você veste essa blusa, você abraça uma causa, espalha informação e inspira transformação.
Adquira uma blusa e ajude a manter o site no ar e a fortalecer a disseminação de conhecimento sobre o Parkinson
Pequenas palavras que fazem uma grande diferença
ION859, an injectable treatment being developed by Ionis Pharmaceuticals, was generally safe and well tolerated, and it reduced the levels of LRRK2 — a protein often overactive in Parkinson’s disease — even in patients without mutations in the gene that encodes it. These are data from a now-completed Phase 1 clinical study, REASON (NCT03976349), which […]
The post AAN 2025: ION859 safely reduces LRRK2 protein in Parkinson’s appeared first on Parkinson's News Today.
My family was feeling very helpless and alone after my husband, Arman, was diagnosed with early-onset Parkinson’s disease in 2009. He was only 38 years old then, and we were left floundering for a sense of hope. Soon after his diagnosis, close friends and family members approached me with the idea of fundraising for Parkinson’s […]
The post Getting involved in fundraising for Parkinson’s was deeply satisfying appeared first on Parkinson's News Today.
Serina Therapeutics will use $5 million in new funding to further develop SER-252 (POZ-apomorphine) as a treatment for advanced Parkinson’s disease, with a Phase 1 clinical study now expected by the end of the year. The company secured the financing from shareholders to support clinical testing of SER-252, its lead treatment candidate, according to a Serina […]
The post Serina using $5M to develop SER-252 for advanced Parkinson’s appeared first on Parkinson's News Today.
It can be hard not to catastrophize everything that happens to you when you have an underlying chronic disease like Parkinson’s. Indeed, Parkinson’s can cause myriad symptoms. Stiffness and joint pain, gait problems, slurred speech, difficulty typing or using touch-screen technology — this disease is insidious and can show up in so many ways. Teasing […]
The post Pay attention to signs of Parkinson’s, but don’t catastrophize appeared first on Parkinson's News Today.
Treatment for up to three years with Onapgo (apomorphine hydrochloride) — approved in the U.S. earlier this year as an add-on therapy for advanced Parkinson’s disease — significantly and sustainably reduced off time, when symptoms are not fully controlled, in adults with the neurodegenerative condition. Importantly, the researchers noted, reductions in off periods were matched […]
The post AAN 2025: Less off time, more good on time with long-term Onapgo appeared first on Parkinson's News Today.
Although physical exercise has well-established benefits for people with Parkinson’s disease, too much of it may worsen fatigue and motor symptoms, according to a report of two cases in the U.K. Both patients believed that intense exercise could help them overcome the disease, including reversing the degeneration of dopaminergic neurons, the nerve cells that are […]
The post Excess exercise may worsen Parkinson’s symptoms, report says appeared first on Parkinson's News Today.
I love a good routine. Every morning, I have a cup of tea and a bowl of oatmeal for breakfast, and I’ve been doing that for at least 10 years. It’s super satisfying, and I see no reason to change it. Every night, my husband, John, and I watch “Jeopardy!” and yell answers at the […]
The post My daily routines are getting a much-needed spring cleanup appeared first on Parkinson's News Today.
A wearable sensor that’s designed to monitor and improve swallowing led to increased swallowing frequency for people with Parkinson’s disease in a small clinical study. The scientists believe the sensors are useful for continuous monitoring of swallowing dysfunction, or dysphagia, in Parkinson’s, and may be a way to help ease the symptom. “This tailored digital […]
The post Wearable sensors may help monitor, ease Parkinson’s swallowing issues appeared first on Parkinson's News Today.
Tavapadon, an orally available small molecule being developed for Parkinson’s disease, was generally safe and eased motor symptoms within one month of being administered at either a fixed or flexible dose to adults with early-stage disease. It also reduced the risk of common side effects typically associated with similar classes of drugs. These data come from […]
The post AAN 2025: Tavapadon offers rapid, sustained motor benefits appeared first on Parkinson's News Today.
A new study in juvenile zebra finches — a songbird species known for singing to attract mates — shows that mastering complex natural behaviors like singing depends on dopamine, a key signaling chemical that is lacking in the brains of people with Parkinson’s disease. The findings of this novel research, led by scientists at the […]
The post Songbirds spark insights into role of dopamine in learning: Study appeared first on Parkinson's News Today.
Artigos
